Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2015
Pharma News, 2015
Allergan and Gedeon Richter Plc. Receive FDA Approval of VRAYLAR™ (cariprazine) for Treatment of Manic or Mixed Episodes of Bipolar I Disorder and Schizophrenia in Adults
DUBLIN and BUDAPEST, Hungary, Sept.
FDA asks Pfizer for Zoloft label update highlighting birth defect risks
For years, Pfizer ($PFE) has shrugged off claims that its antidepressant Zoloft causes heart defects in newborns, fighting a raft of litigation alleging that the company did not adequately war...
Ventrix Initiates Clinical Trial of VentriGel
SAN DIEGO, CA, USA September 17, 2015.
Invokana diabetes drug faces Canadian class-action lawsuit
The diabetes drug Invokana, recently adopted by Nova Scotia's pharmacare program, is now the subject of a national class-action lawsuit.
Amgen bets up to $1.7B on Xencor's antibody technology
Amgen ($AMGN) is teaming up with Xencor ($XNCR) through a heavily back-loaded deal worth as much as $1.
Nurix, Celgene partner to develop new therapies for oncology immunology and immuno-oncology
Nurix and Celgene have partnered to develop and commercialize novel small molecule therapeutics in the fields of oncology, inflammation, immunology and immuno-oncology.
FDA Warnings Target Drug Companies in New Zealand, India
Sept.
Bristol-Myers Squibb’s Opdivo (nivolumab) Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for Advanced Renal Cell Carcinoma
PRINCETON, N.
Obama nominates Robert Califf as FDA commissioner
President Barack Obama has nominated Dr.
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Competition is heating up in the GLP-1 diabetes market, and Novo Nordisk ($NVO) is doing what it can to line up data behind its long-dominant drug, Victoza.
Takeda joins WIPO Re:Search to accelerate R&D of new drugs for neglected tropical diseases, malaria, TB
Takeda Pharmaceutical Company Limited, a research-based global company, announced its participation in WIPO Re.
Mylan Opens $27.14 Billion Hostile Bid for Perrigo
Shares of Mylan are edging up before the opening bell after the pharmaceutical company went ahead with its hostile, $27.
15
16
17
18
19
20
21
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds
